Topiramate vs Erenumab
Jan 14, 2022•19 min•Ep. 110
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The HER-MES trial is a newly published study comparing the tolerability and efficacy of topiramate (Topamax) and erenumab (Aimovig). The results of this trial could impact prescribing practices and payor policies. Tune in this afternoon for this episode of Heads UP as Lindsay Weitzel, PhD, and Tim Smith, MD, discuss the important aspects of the HER-MES trial.
For the best experience, listen in Metacast app for iOS or Android